Ayala Pharmaceuticals CEO Roni Mamluk's 2020 pay jumps 150% to $1.7M
Ayala Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Ayala Pharmaceuticals reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, three executives at Ayala Pharmaceuticals received on average a compensation package of $1.1M, a 44% increase compared to previous year.
Average pay of disclosed executives at Ayala Pharmaceuticals
Roni Mamluk, Chief Executive Officer, received $1.7M in total, which increased by 150% compared to 2019. 41% of Mamluk's compensation, or $709K, was in stock awards. Mamluk also received $146K in non-equity incentive plan, $398K in option awards, $362K in salary, as well as $128K in other compensation.
Yossi Maimon, Chief Financial Officer, received a compensation package of $862K, which increased by 19% compared to previous year. 33% of the compensation package, or $288K, was in salary.
Gary Gordon, Chief Medical Officer, earned $550K in 2020, a 29% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2021.